Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2020 Filed Feb 26, 2020 18:36 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $360.95 | $72,190.00 |
DisclosureSEC source: 0000096943-20-000019 · wf-form4_158274217553577.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 18:36 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000019 · wf-form4_158274217553577.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 00:49 UTC |
Leyden James JVP, General Counsel, Secretary
|
GrantStock Option / (Right to Buy) · Derivative | 5,996 | $0.00 Strike: $348.11 | $0.00 |
DisclosureSEC source: 0000096943-20-000031 · wf-form4_158285097575476.xml · derivative · entry 7 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,996 Underlying: Common Stock · 5,996 shares Expires 2030-02-25 F2 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/25/2021, 2/25/2022 and 2/25/2023. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 00:49 UTC |
Leyden James JVP, General Counsel, Secretary
|
GrantCommon Stock | 614 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000031 · wf-form4_158285097575476.xml · nonDerivative · entry 1 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,141 F1 · kind: Restricted Stock Award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest 100% on the third anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 22:27 UTC |
Deren JohnVP & Chief Accounting Officer
|
GrantStock Option / (Right to Buy) · Derivative | 2,167 | $0.00 Strike: $348.11 | $0.00 |
DisclosureSEC source: 0000096943-20-000033 · wf-form4_158292883019993.xml · derivative · entry 3 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167 Underlying: Common Stock · 2,167 shares Expires 2030-02-25 F2 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/25/2021, 2/25/2022 and 2/25/2023. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 22:27 UTC |
Deren JohnVP & Chief Accounting Officer
|
GrantCommon Stock | 222 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000033 · wf-form4_158292883019993.xml · nonDerivative · entry 1 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,233 F1 · kind: Restricted Stock Award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest 100% on the third anniversary of the grant date. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 17:16 UTC |
SMITH BENSONDirector
|
Tax withholdingCommon Stock | 1,106 | $376.44 | $416,342.64 |
DisclosureSEC source: 0000096943-20-000009 · wf-form4_158213255105656.xml · nonDerivative · entry 1 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,860.637 F1 · kind: Shares withheld to satisfy tax liability upon distribution from Teleflex Incorporated's Deferred Compensation Plan. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 19:56 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000003 · wf-form4_158024136166413.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 19:56 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $375.71 | $75,142.00 |
DisclosureSEC source: 0000096943-20-000003 · wf-form4_158024136166413.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 736 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 19:56 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000003 · wf-form4_158024136166413.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| December 26, 2019 Filed Dec 26, 2019 22:43 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $61.34 | $0.00 |
DisclosureSEC source: 0000096943-19-000198 · wf-form4_157740017439309.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| December 26, 2019 Filed Dec 26, 2019 22:43 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $374.35 | $74,870.00 |
DisclosureSEC source: 0000096943-19-000198 · wf-form4_157740017439309.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 736 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| December 26, 2019 Filed Dec 26, 2019 22:43 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $61.34 | $12,268.00 |
DisclosureSEC source: 0000096943-19-000198 · wf-form4_157740017439309.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 21:09 UTC |
Hicks Cameron PVice President, Global HR
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $85.54 | $0.00 |
DisclosureSEC source: 0000096943-19-000196 · wf-form4_157532093664152.xml · derivative · entry 2 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,892 Underlying: Common Stock · 1,000 shares Expires 2023-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable for one-third of the shares on each of 4/8/2014, 4/8/2015 and 4/8/2016. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 21:09 UTC |
Hicks Cameron PVice President, Global HR
|
Exercise / conversionCommon Stock | 1,000 | $85.54 | $85,540.00 |
DisclosureSEC source: 0000096943-19-000196 · wf-form4_157532093664152.xml · nonDerivative · entry 1 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,106.02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 23:13 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $121.00 | $0.00 |
DisclosureSEC source: 0000096943-19-000192 · wf-form4_157480996480089.xml · derivative · entry 5 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,339 Underlying: Common Stock · 5,000 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F4 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/25/2016, 2/25/2017 and 2/25/2018. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 23:13 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
SaleCommon Stock | 4,000 | $349.05 | $1,396,200.00 |
DisclosureSEC source: 0000096943-19-000192 · wf-form4_157480996480089.xml · nonDerivative · entry 3 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,697 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $349.00 to $349.35. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 23:13 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
SaleCommon Stock | 1,000 | $347.31 | $347,310.00 |
DisclosureSEC source: 0000096943-19-000192 · wf-form4_157480996480089.xml · nonDerivative · entry 2 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,697 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $347.07 to $347.73. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 23:13 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 5,000 | $121.00 | $605,000.00 |
DisclosureSEC source: 0000096943-19-000192 · wf-form4_157480996480089.xml · nonDerivative · entry 1 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 22:53 UTC |
Hicks Cameron PVice President, Global HR
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $85.54 | $0.00 |
DisclosureSEC source: 0000096943-19-000195 · wf-form4_157489518980666.xml · derivative · entry 5 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,892 Underlying: Common Stock · 1,300 shares Expires 2023-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable for one-third of the shares on each of 4/8/2014, 4/8/2015 and 4/8/2016. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 22:53 UTC |
Hicks Cameron PVice President, Global HR
|
SaleCommon Stock | 1,300 | $350.00 | $455,000.00 |
DisclosureSEC source: 0000096943-19-000195 · wf-form4_157489518980666.xml · nonDerivative · entry 3 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,106.02 Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 22:53 UTC |
Hicks Cameron PVice President, Global HR
|
Exercise / conversionCommon Stock | 1,300 | $85.54 | $111,202.00 |
DisclosureSEC source: 0000096943-19-000195 · wf-form4_157489518980666.xml · nonDerivative · entry 2 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,406.02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 22:35 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $61.34 | $0.00 |
DisclosureSEC source: 0000096943-19-000190 · wf-form4_157480770686022.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Underlying: Common Stock · 200 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 22:35 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $346.63 | $69,326.00 |
DisclosureSEC source: 0000096943-19-000190 · wf-form4_157480770686022.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 736 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 22:35 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $61.34 | $12,268.00 |
DisclosureSEC source: 0000096943-19-000190 · wf-form4_157480770686022.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 22:53 UTC |
Hicks Cameron PVice President, Global HR
|
GiftCommon Stock | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-19-000195 · wf-form4_157489518980666.xml · nonDerivative · entry 1 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,106.02 Read SEC document |
| November 13, 2019 Filed Feb 6, 2020 17:19 UTC |
Leyden James JVP, General Counsel, Secretary
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000005 · wf-form5_158100954646366.xml · nonDerivative · entry 2 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,527 Read SEC document |
| November 13, 2019 Filed Feb 6, 2020 17:19 UTC |
Leyden James JVP, General Counsel, Secretary
|
GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000005 · wf-form5_158100954646366.xml · nonDerivative · entry 1 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,627 Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 00:05 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $121.00 | $0.00 |
DisclosureSEC source: 0000096943-19-000185 · wf-form4_157360353503112.xml · derivative · entry 6 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,339 Underlying: Common Stock · 7,500 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F5 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/25/2016, 2/25/2017 and 2/25/2018. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 00:05 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
SaleCommon Stock | 5,287 | $331.11 | $1,750,578.57 |
DisclosureSEC source: 0000096943-19-000185 · wf-form4_157360353503112.xml · nonDerivative · entry 4 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,697 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $330.54 to $331.34. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 00:05 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
SaleCommon Stock | 1,868 | $329.87 | $616,197.16 |
DisclosureSEC source: 0000096943-19-000185 · wf-form4_157360353503112.xml · nonDerivative · entry 3 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,984 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $329.29 to $330.11. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 00:05 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
SaleCommon Stock | 345 | $328.03 | $113,170.35 |
DisclosureSEC source: 0000096943-19-000185 · wf-form4_157360353503112.xml · nonDerivative · entry 2 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,852 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $327.95 to $328.04. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 00:05 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 7,500 | $121.00 | $907,500.00 |
DisclosureSEC source: 0000096943-19-000185 · wf-form4_157360353503112.xml · nonDerivative · entry 1 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:00 UTC |
SMITH BENSONDirector
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 8,481 | $0.00 Strike: $59.75 | $0.00 |
DisclosureSEC source: 0000096943-19-000183 · wf-form4_157307759068874.xml · derivative · entry 9 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,481 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. F6 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/28/2013, 2/28/2014 and 2/28/2015. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:00 UTC |
SMITH BENSONDirector
|
SaleCommon Stock | 400 | $347.76 | $139,104.00 |
DisclosureSEC source: 0000096943-19-000183 · wf-form4_157307759068874.xml · nonDerivative · entry 6 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,808.977 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $347.755 to $347.76. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:00 UTC |
SMITH BENSONDirector
|
SaleCommon Stock | 113 | $346.50 | $39,154.50 |
DisclosureSEC source: 0000096943-19-000183 · wf-form4_157307759068874.xml · nonDerivative · entry 5 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,208.977 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:00 UTC |
SMITH BENSONDirector
|
SaleCommon Stock | 4,163 | $345.89 | $1,439,940.07 |
DisclosureSEC source: 0000096943-19-000183 · wf-form4_157307759068874.xml · nonDerivative · entry 4 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,321.977 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $345.49 to $346.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:00 UTC |
SMITH BENSONDirector
|
SaleCommon Stock | 2,405 | $345.03 | $829,797.15 |
DisclosureSEC source: 0000096943-19-000183 · wf-form4_157307759068874.xml · nonDerivative · entry 3 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,484.977 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $344.46 to $345.42. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:00 UTC |
SMITH BENSONDirector
|
SaleCommon Stock | 1,400 | $343.66 | $481,124.00 |
DisclosureSEC source: 0000096943-19-000183 · wf-form4_157307759068874.xml · nonDerivative · entry 2 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,889.977 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $343.28 to $344.26. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:00 UTC |
SMITH BENSONDirector
|
Exercise / conversionCommon Stock | 8,481 | $59.75 | $506,739.75 |
DisclosureSEC source: 0000096943-19-000183 · wf-form4_157307759068874.xml · nonDerivative · entry 1 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,289.977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:19 UTC |
SMITH BENSONDirector
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $59.75 | $0.00 |
DisclosureSEC source: 0000096943-19-000181 · wf-form4_157264316512728.xml · derivative · entry 6 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,481 Underlying: Common Stock · 17,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. F2 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/28/2013, 2/28/2014 and 2/28/2015. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:19 UTC |
SMITH BENSONDirector
|
SaleCommon Stock | 427 | $340.28 | $145,297.43 |
DisclosureSEC source: 0000096943-19-000181 · wf-form4_157264316512728.xml · nonDerivative · entry 3 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,808.977 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:19 UTC |
SMITH BENSONDirector
|
SaleCommon Stock | 16,573 | $340.00 | $5,634,820.00 |
DisclosureSEC source: 0000096943-19-000181 · wf-form4_157264316512728.xml · nonDerivative · entry 2 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,235.977 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:19 UTC |
SMITH BENSONDirector
|
Exercise / conversionCommon Stock | 17,000 | $59.75 | $1,015,750.00 |
DisclosureSEC source: 0000096943-19-000181 · wf-form4_157264316512728.xml · nonDerivative · entry 1 SMITH BENSON · CIK 0001211667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,808.977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 21, 2019. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 22:31 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $121.00 | $0.00 |
DisclosureSEC source: 0000096943-19-000179 · wf-form4_157256108860731.xml · derivative · entry 6 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,839 Underlying: Common Stock · 7,500 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F5 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/25/2016, 2/25/2017 and 2/25/2018. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 22:31 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
SaleCommon Stock | 3,819 | $328.05 | $1,252,822.95 |
DisclosureSEC source: 0000096943-19-000179 · wf-form4_157256108860731.xml · nonDerivative · entry 4 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,697 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $328.00 to $328.56. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 22:31 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
SaleCommon Stock | 3,216 | $326.96 | $1,051,503.36 |
DisclosureSEC source: 0000096943-19-000179 · wf-form4_157256108860731.xml · nonDerivative · entry 3 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,516 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $326.39 to $327.11. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 22:31 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
SaleCommon Stock | 465 | $325.36 | $151,292.40 |
DisclosureSEC source: 0000096943-19-000179 · wf-form4_157256108860731.xml · nonDerivative · entry 2 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,732 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $325.13 to $325.58. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 22:31 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 7,500 | $121.00 | $907,500.00 |
DisclosureSEC source: 0000096943-19-000179 · wf-form4_157256108860731.xml · nonDerivative · entry 1 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019. Read SEC document |
| October 25, 2019 Filed Oct 25, 2019 23:20 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $61.34 | $0.00 |
DisclosureSEC source: 0000096943-19-000164 · wf-form4_157204561628296.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 200 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.